|
SMCR7L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64734892393881E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.07638375779607E-12 |
| Normal-vs-Stage2 |
2.023900E-04 |
| Normal-vs-Stage3 |
5.04496444619917E-12 |
| Normal-vs-Stage4 |
3.92996746256813E-12 |
| Stage1-vs-Stage2 |
1.868640E-01 |
| Stage1-vs-Stage3 |
1.922160E-01 |
| Stage1-vs-Stage4 |
2.603700E-03 |
| Stage2-vs-Stage3 |
3.978100E-02 |
| Stage2-vs-Stage4 |
2.978600E-03 |
| Stage3-vs-Stage4 |
1.034210E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.36779476633819E-13 |
| Normal-vs-AfricanAmerican |
1.95506999999262E-05 |
| Normal-vs-Asian |
1.12730000001449E-07 |
| Caucasian-vs-AfricanAmerican |
6.877400E-01 |
| Caucasian-vs-Asian |
8.356200E-01 |
| AfricanAmerican-vs-Asian |
8.334000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.43610012770523E-10 |
| Normal-vs-Female |
1.70641278884887E-12 |
| Male-vs-Female |
3.699200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.18819962150008E-10 |
| Normal-vs-Age(41-60Yrs) |
7.43849426498855E-13 |
| Normal-vs-Age(61-80Yrs) |
8.74549987983642E-10 |
| Normal-vs-Age(81-100Yrs) |
1.362240E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.761000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.611000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.949200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.889000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.395600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.667400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.599400E-01 |
| Classical-VS-Follicular |
2.280600E-01 |
| Classical-VS-Other |
8.403600E-02 |
| Classical-VS-Normal |
1.93019999983335E-08 |
| Tall-VS-Follicular |
8.321000E-01 |
| Tall-VS-Other |
4.301000E-01 |
| Tall-VS-Normal |
5.25129999484619E-08 |
| Follicular-VS-Other |
2.997200E-01 |
| Follicular-VS-Normal |
4.66700000867348E-09 |
| Other-VS-Normal |
5.150600E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.30510088583947E-11 |
| Normal-vs-N1 |
3.73230335526387E-11 |
| N0-vs-N1 |
1.315560E-02 |
|
|
